Skip to content
Use caution Drug recall · FDA · Published December 4, 2017

Solco Recalls Gabapentin 800mg Due to Label Mix-Up

Solco Healthcare recalls specific lots of Gabapentin 800mg tablets because bottles labeled as 800 mg may actually contain 600 mg.

🇺🇸 FDA recall #D-0155-2018DrugSolco Healthcare ›
Take action

Contact the company

Recalling firmSolco Healtcare US LLC2002 Eastpark Blvd Ste A · Cranbury, NJ 08512-3514
✎ GovInfoNow plain-language explainer

What happened, in plain English

Solco Healthcare US LLC is recalling a specific lot of Gabapentin Tablets, USP, 800 mg, distributed in Mason, OH. The issue involves a labeling error where some bottles marked as containing 800 mg tablets actually contain 600 mg tablets. This discrepancy could lead to patients receiving an incorrect dosage. Read more at govinfonow.com/recall/41031-solco-recalls-gabapentin-800mg-due-to-label-mix-up.

Source Summary by GovInfoNow · govinfonow.com/recall/41031-solco-recalls-gabapentin-800mg-due-to-label-mix-up · Updated October 11, 2026 · FDA enforcement record: FDA #D-0155-2018

Cite this page

“Solco Recalls Gabapentin 800mg Due to Label Mix-Up.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41031-solco-recalls-gabapentin-800mg-due-to-label-mix-up. Based on FDA recall #D-0155-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0155-2018%22&limit=1).

Why it’s dangerous

The hazard is a labeling mix-up where bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg. Taking the wrong dose can result in under-treatment if more pills are taken to compensate, or over-medication if the patient assumes the label is correct but the content is different.

Who’s affected

Patients in Mason, OH, who purchased or were prescribed the recalled Gabapentin Tablets from this specific distribution lot are affected. Individuals relying on the precise 800 mg dosage for their treatment are at risk of receiving an incorrect strength.

How to tell if you have this one

Check for Gabapentin Tablets, USP, 800 mg, 500-count, Rx only. Look for NDC 43547-0333-50 and Lot # 7700656A. The product was distributed by Solco Healthcare US LLC in Mason, OH.

  • Brand
    Solco Healthcare
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your Gabapentin bottles match NDC 43547-0333-50 and Lot # 7700656A.

  2. Contact your pharmacist

    If you have the recalled product, speak with your pharmacist or healthcare provider immediately to determine the next steps for replacement or disposal.

Where it went and when

Where it was distributed

Distributed in Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Product was distributed in Mason, OH.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Ohio.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Dec 4, 201712. FDA classified it Class II: Jan 5, 201823. Published in FDA’s Enforcement Report: Jan 17, 201834. FDA terminated the recall: Feb 25, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0155-2018 (December 4, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0155-2018 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA